Curcumin

Curcumin

SCHEMBL20291461

COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O.O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.68
▸ KMT2A Q03164 7/20 0.68
▸ CYP1A2 P05177 6/20 0.68
▸ CYP1A1 P04798 4/20 0.68
▸ CYP1B1 Q16678 4/20 0.68
▸ IPMK Q8NFU5 3/20 0.68
▸ IP6K2 Q9UHH9 3/20 0.68
▸ CA12 O43570 3/20 0.68
▸ CA2 P00918 3/20 0.68
▸ CA4 P22748 3/20 0.68
▸ CA7 P43166 3/20 0.68
▸ XDH P47989 3/20 0.68
▸ PPARG P37231 2/20 0.68
▸ NOX4 Q9NPH5 2/20 0.63
▸ MAPT P10636 7/20 0.61
▸ HSD17B10 Q99714 6/20 0.61
▸ APP P05067 6/20 0.61
▸ KDM4E B2RXH2 5/20 0.61
▸ ABCB1 P08183 5/20 0.61
▸ RECQL P46063 4/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Curcumin SCHEMBL21049944 0.95 MEN1 (0.62) MEN1KMT2ACYP1A2CYP1A1CYP1B1
Quercetin SCHEMBL8442487 0.92 MEN1 (0.70) MEN1KMT2ACYP1A2CYP1A1CYP1B1
Isorhamnetin SCHEMBL3715283 0.86 MEN1 (0.93) MEN1KMT2ACYP1A2CYP1A1CYP1B1
SCHEMBL8442485 0.84 POLH (0.64) MEN1KMT2ACYP1A2CYP1A1CYP1B1
Isorhamnetin SCHEMBL29390102 0.82 MEN1 (1.00) MEN1KMT2ACYP1A2CYP1A1CYP1B1
Isorhamnetin SCHEMBL29377152 0.82 MEN1 (1.00) MEN1KMT2ACYP1A2CYP1A1CYP1B1
Isorhamnetin SCHEMBL19235 0.82 MEN1 (1.00) MEN1KMT2ACYP1A2CYP1A1CYP1B1
Isorhamnetin SCHEMBL30385934 0.82 MEN1 (1.00) MEN1KMT2ACYP1A2CYP1A1CYP1B1
SCHEMBL13846231 0.81 POLH (0.59) MEN1KMT2ACYP1A2CYP1A1CYP1B1
SCHEMBL13846131 0.81 POLH (0.53) MEN1KMT2ACYP1A2CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3338769-A1 FORMULATIONS FOR USE IN THE TREATMENT OF ENDOMETRIOSIS AND DISORDERS THEREWITH ASSOCIATED Inpha Duemila S.r.l. (IT) 2018-06-27 — — EP disclosed
Send feedback